ACM
AIGH Capital Management Portfolio holdings
AUM
$213M
This Quarter Return
+2.1%
1 Year Return
+95.37%
3 Year Return
+329.16%
5 Year Return
–
10 Year Return
–
AUM
$205M
AUM Growth
+$205M
(-1.2%)
Cap. Flow
+$5.1M
Cap. Flow
% of AUM
2.49%
Top 10 Holdings %
Top 10 Hldgs %
64.62%
Holding
49
New
5
Increased
13
Reduced
8
Closed
10
Top Buys
| 1 |
Silicon Motion
SIMO
|
$22.3M |
| 2 |
INFN
Infinera Corporation Common Stock
INFN
|
$15.1M |
| 3 |
Arq
ARQ
|
$13M |
| 4 |
Elutia
ELUT
|
$6.25M |
| 5 |
Biodesix
BDSX
|
$3.76M |
Top Sells
| 1 |
Ouster
OUST
|
$14.7M |
| 2 |
Kiora Pharmaceuticals
KPRX
|
$8.59M |
| 3 |
Humacyte
HUMA
|
$6.71M |
| 4 |
Fennec Pharmaceuticals
FENC
|
$6.34M |
| 5 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$5.93M |
Sector Composition
| 1 | Healthcare | 56.27% |
| 2 | Technology | 28.96% |
| 3 | Industrials | 14.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Silicon Motion
SIMO
$2.71B
| $22.3M | 6.94% | +275,000 | New | +$22.3M |
|
|
INFN
2
DELISTED
Infinera Corporation Common Stock
INFN
| $20.5M | 6.39% | 3,368,556 +2,479,272 | +279% | +$15.1M |
|
3
Delcath Systems
DCTH
$385M
| $20.1M | 6.26% | 2,399,792 +40,064 | +2% | +$335K |
|
4
scPharmaceuticals
SCPH
$295M
| $15.2M | 4.75% | 3,504,365 +115,206 | +3% | +$501K |
|
|
5
Arq
ARQ
$330M
| $13M | 4.05% | +2,142,078 | New | +$13M |
|
6
Myomo
MYO
$39.7M
| $9.37M | 2.92% | 2,917,997 +115,405 | +4% | +$370K |
|
|
7
Biodesix
BDSX
$62.6M
| $8.84M | 2.75% | 5,779,812 +2,458,727 | +74% | +$3.76M |
|
|
8
Elutia
ELUT
$96.7M
| $8.42M | 2.62% | 1,697,316 +1,260,750 | +289% | +$6.25M |
|
9
TELA Bio
TELA
$70.5M
| $7.79M | 2.43% | 1,656,655 +241,400 | +17% | +$1.13M |
|
10
Cellectar Biosciences
CLRB
$15.5M
| $6.86M | 2.14% | 3,036,187 +231,270 | +8% | +$523K |
|
|
EGRX
11
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.78M | 2.11% | 1,211,509 +25,000 | +2% | +$140K |
|
|
ELVA
12
Electrovaya
ELVA
$243M
| $6.64M | 2.07% | 2,575,428 -1,544,513 | -37% | -$3.98M |
|
13
Intellicheck
IDN
$109M
| $6.05M | 1.88% | 1,767,732 +253,706 | +17% | +$868K |
|
14
Red Cat Holdings
RCAT
$892M
| $5.66M | 1.76% | 4,920,601 -44,272 | -0.9% | -$50.9K |
|
|
PROF
15
Profound Medical
PROF
$134M
| $5.44M | 1.69% | 646,733 | – | – |
|
|
THTX
16
Theratechnologies
THTX
$149M
| $5.23M | 1.63% | 3,725,204 | – | – |
|
17
Ideal Power
IPWR
$44.5M
| $4.94M | 1.54% | 700,000 | – | – |
|
18
Lightpath Technologies
LPTH
$230M
| $4.69M | 1.46% | 3,723,932 +200,000 | +6% | +$252K |
|
19
Coya Therapeutics
COYA
$110M
| $3.94M | 1.23% | 649,427 | – | – |
|
20
BK Technologies
BKTI
$264M
| $3.62M | 1.13% | 282,772 -48,124 | -15% | -$616K |
|
21
Immix Biopharma
IMMX
$64M
| $2.79M | 0.87% | 1,406,680 -148,320 | -10% | -$294K |
|
22
Aprea Therapeutics
APRE
$9.09M
| $2.19M | 0.68% | 539,300 | – | – |
|
23
PolyPid
PYPD
$53.3M
| $2.05M | 0.64% | 479,246 | – | – |
|
24
Beyond Air
XAIR
$11.6M
| $1.96M | 0.61% | 3,638,878 -75,580 | -2% | -$40.6K |
|
|
GRCE
25
Grace Therapeutics, Inc. Common Stock
GRCE
$41.9M
| $1.88M | 0.59% | 641,083 +143,724 | +29% | +$422K |
|